FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 79 filers reported holding FATE THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $334,341 | -58.7% | 101,933 | -7.5% | 0.00% | 0.0% |
| Q1 2024 | $809,225 | -7.4% | 110,248 | -52.8% | 0.00% | -50.0% |
| Q4 2023 | $874,217 | +136.3% | 233,748 | +34.0% | 0.00% | +100.0% |
| Q3 2023 | $369,899 | -58.5% | 174,481 | -6.9% | 0.00% | -50.0% |
| Q2 2023 | $892,383 | -9.0% | 187,476 | +8.9% | 0.00% | 0.0% |
| Q1 2023 | $980,911 | +18279.4% | 172,090 | +32431.2% | 0.00% | – |
| Q4 2022 | $5,337 | -51.5% | 529 | 0.0% | 0.00% | – |
| Q3 2022 | $11,000 | -15.4% | 529 | 0.0% | 0.00% | – |
| Q2 2022 | $13,000 | -35.0% | 529 | 0.0% | 0.00% | – |
| Q1 2022 | $20,000 | -33.3% | 529 | 0.0% | 0.00% | – |
| Q4 2021 | $30,000 | -3.2% | 529 | 0.0% | 0.00% | – |
| Q3 2021 | $31,000 | -92.7% | 529 | -89.3% | 0.00% | -100.0% |
| Q2 2021 | $427,000 | -86.6% | 4,924 | -87.3% | 0.00% | -83.3% |
| Q1 2021 | $3,192,000 | -41.2% | 38,736 | -35.1% | 0.01% | -45.5% |
| Q4 2020 | $5,426,000 | +99.0% | 59,648 | -12.6% | 0.01% | +83.3% |
| Q3 2020 | $2,726,000 | +16.6% | 68,251 | 0.0% | 0.01% | +20.0% |
| Q2 2020 | $2,338,000 | +6.2% | 68,251 | -31.1% | 0.01% | -16.7% |
| Q1 2020 | $2,201,000 | -28.5% | 99,078 | -37.0% | 0.01% | 0.0% |
| Q4 2019 | $3,078,000 | +118.6% | 157,358 | +73.5% | 0.01% | +100.0% |
| Q3 2019 | $1,408,000 | +501.7% | 90,677 | +53.3% | 0.00% | – |
| Q3 2017 | $234,000 | – | 59,168 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $197,709,000 | 22.51% |
| Redmile Group, LLC | 12,957,222 | $758,127,000 | 17.24% |
| Grosvenor Holdings, L.L.C. | 1,037,256 | $60,690,000 | 6.28% |
| Casdin Capital, LLC | 3,400,000 | $198,934,000 | 5.61% |
| Ally Bridge Group (NY) LLC | 270,000 | $15,798,000 | 5.52% |
| DAFNA Capital Management LLC | 372,160 | $21,775,000 | 5.48% |
| Tri Locum Partners LP | 142,032 | $8,310,000 | 3.27% |
| Kynam Capital Management, LP | 95,561 | $5,591,000 | 2.99% |
| Artal Group S.A. | 1,800,000 | $105,318,000 | 2.86% |
| Bellevue Group AG | 3,775,736 | $220,918,000 | 2.28% |